Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients. (2008)

First Author: Kenny LM
Attributed to:  Molecular Therapy funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier:

PubMed Identifier: 18483090

Publication URI:

Type: Journal Article/Review

Volume: 49

Parent Publication: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Issue: 6

ISSN: 0161-5505